KCM

Knoll Capital Management Portfolio holdings

AUM $141M
This Quarter Return
+2.24%
1 Year Return
+51.8%
3 Year Return
+256.4%
5 Year Return
+482.18%
10 Year Return
+5,137.57%
AUM
$193M
AUM Growth
+$193M
Cap. Flow
-$6.87M
Cap. Flow %
-3.55%
Top 10 Hldgs %
99.1%
Holding
18
New
4
Increased
2
Reduced
3
Closed
1
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
MDVN
1
DELISTED
MEDIVATION, INC.
MDVN
$147M 75.94% 2,279,519 -204,582 -8% -$13.2M
AMPE
2
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$18.8M 9.74% 2,964,401 +937,403 +46% +$5.95M
ARCT icon
3
Arcturus Therapeutics
ARCT
$462M
$12.5M 6.45% 687,000
TOVX icon
4
Theriva Biologics
TOVX
$3.94M
$3.5M 1.81% 1,360,000
KERX
5
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$3.41M 1.76% 200,000
LUMO
6
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$2.2M 1.14% 77,437
NWBO
7
DELISTED
Northwest Biotherapeutics, Inc. Common stock
NWBO
$1.45M 0.75% +200,300 New +$1.45M
INO icon
8
Inovio Pharmaceuticals
INO
$126M
$1.36M 0.7% 408,352
MACK
9
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$809K 0.42% 160,585 +85,585 +114% +$431K
GLMD icon
10
Galmed Pharmaceuticals
GLMD
$6.96M
$746K 0.39% +65,000 New +$746K
ADXS
11
DELISTED
Advaxis, Inc.
ADXS
$706K 0.37% 225,000
NRX
12
DELISTED
NEPHROGENEX INC COM
NRX
$412K 0.21% +50,000 New +$412K
PRKR
13
DELISTED
Parkervision Inc
PRKR
$240K 0.12% 50,000 -150,000 -75% -$720K
AKTX
14
Akari Therapeutics
AKTX
$24.8M
$151K 0.08% +23,255 New +$151K
ADXSW
15
DELISTED
Advaxis, Inc. Warrants
ADXSW
$141K 0.07% 112,500
ECTE
16
DELISTED
ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE)
ECTE
$86K 0.04% 28,630 -15,815 -36% -$47.5K
SQNM
17
DELISTED
SEQUENOM INC NEW
SQNM
-893,600 Closed -$2.07M
VVUS
18
DELISTED
Vivus Inc
VVUS
0